Access practice tools, as well as industry leading news, customizable alerts, dockets, and primary content, including a comprehensive collection of case law, dockets, and regulations. Leverage...
By Tony Dutra
Reckitt Benckiser LLC knocked out two patents being asserted against its Durex Real Feel condoms at the Patent and Trademark Office.
Ansell Healthcare Products LLC, headquartered in Iselin, N.J., sued U.K.-based Reckitt in the U.S. District Court of Delaware for allegedly infringing four patents on producing synthetic polyisoprene articles. Reckitt challenged the two newest of the four patents at the PTO’s Patent Trial and Appeal Board.
The parties already agreed that the portion of Ansell’s complaint related to those patents would be removed from consideration by the jury in the district court case. Trial is set for Feb. 20.
The PTAB ruled that the newer claims, filed in 2013, were an attempt to expand the scope of Ansell’s patent protection beyond what was supported by the description, which was filed in 2008.
Reckitt didn’t challenge the older patents at the PTAB. The jury in the district court case, No. 1:15-cv-00915 (D. Del.), will review Reckitt’s arguments that those patent claims are invalid based on prior inventions from the early 2000s, or are not infringed by the Durex condoms.
Counsel for the parties at the district court—Morgan, Lewis & Bockius LLP for Ansell and Barclay Damon LLP for Reckitt—confirmed the status of the case but declined to comment further on how the PTAB’s rulings might affect the outcome. Sterne, Kessler, Goldstein & Fox PLLC and Moser Taboada represented Ansell before the PTAB.
The PTAB cases are Reckitt Benckiser LLC v. Ansell Healthcare Products LLC , P.T.A.B., No. IPR2017-00063, 1/30/18 , and Reckitt Benckiser LLC v. Ansell Healthcare Products LLC , P.T.A.B., No. IPR2017-00066, 1/30/18
To contact the reporter on this story: Tony Dutra in Washington at email@example.com
To contact the editor responsible for this story: Mike Wilczek at firstname.lastname@example.org
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)